Brind.
Entities  /  Company

Jazz Pharmaceuticals.

Irish tax-registered pharmaceutical corporation

Seen in 117 reportsLast reported Nov 6

Reports this week
0
Active events
0
Connections
111

What's happening

Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday

Gone quiet

No new reports in 90+ days

What's reaching Jazz Pharmaceuticals

Events traced to Jazz Pharmaceuticals, step by step, newest first

Around Jazz Pharmaceuticals this week

News at the entities that move Jazz Pharmaceuticals most

Connections

The 36 strongest of 111, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.
Show all 36 connections
  • Samsung Electronics Operational

    Jazz Pharmaceuticals and Samsung Electronics have formed a strategic partnership to boost AI smartphone accessibility.

    Some supportOct 20
  • Elanco Operational

    The two companies actively compete and operate within the specialized pharmaceutical market segment.

    Some supportAug 4
  • Mark D. Smith Structural

    Mark D. Smith serves as a board member for Jazz Pharmaceuticals.

    Some supportAug 4
  • Johnson & Johnson Operational

    The two companies are major pharmaceutical players who operate in the same competitive market space.

    Some supportAug 30
  • Jazz Pharmaceuticals is subject to the filing and disclosure requirements of the U.S. Securities and Exchange Commission, including the 13F rule.

    Some supportJul 31
  • Jazz Pharmaceuticals' market function is structurally dependent on regulatory approvals granted by the Food and Drug Administration.

    Some supportJun 25
  • TD Cowen Mentioned together

    TD Cowen provides financial analysis, price targets, and ratings for Jazz Pharmaceuticals.

    Some supportNov 6
  • Needham & Company Mentioned together

    Needham & Company provides financial analysis and price target recommendations for Jazz Pharmaceuticals stock.

    Some supportJul 21
  • S&P Mentioned together

    Jazz Pharmaceuticals' revenue performance is tracked against S&P's analyst revenue estimates.

    Some supportNov 2
  • Royal Bank of Canada Mentioned together

    RBC provides financial analysis, price targets, and buy ratings for Jazz Pharmaceuticals.

    Some supportOct 6
  • Bank of America Mentioned together

    BoA conducts market research on Jazz Pharmaceuticals, including monitoring operational risks and issuing price targets.

    Some supportJul 21
  • Benzinga Mentioned together

    Benzinga provides financial news coverage regarding Jazz Pharmaceuticals' earnings.

    Some supportAug 4
  • Samsung Wallet Operational

    The entities are collaborating to support digital payments convenience.

    Some supportOct 20
  • MarketBeat Mentioned together

    MarketBeat tracks and reports on company performance data and analyst ratings for Jazz Pharmaceuticals.

    Well supportedOct 6
  • Norway Shared context

    Jazz Pharmaceuticals operates in Norway, evidenced by the regulatory approval of Ziihera.

    SpeculativeJul 6
  • Leerink partners Mentioned together

    Leerink partners provided a price target update regarding Jazz Pharmaceuticals.

    Some supportJul 21
  • Cannes Shared context

    The company's program was held in Cannes and demonstrated measurable healthcare impact.

    Some supportJun 23
  • Cramer Mentioned together

    Cramer provides investment recommendations regarding Jazz Pharmaceuticals.

    Some supportOct 10
  • Eli Lilly and Company Operational

    Jazz Pharmaceuticals and Eli Lilly are active competitors within the major pharmaceutical stock market.

    Some supportAug 30
  • Jim Cramer Mentioned together

    Jim Cramer provided a positive market recommendation for Jazz Pharmaceuticals on Mad Money.

    Some supportOct 14
  • Zoetis Operational

    Market analysis compares the business strengths and financial performance of Jazz Pharmaceuticals and Zoetis.

    Some supportSep 25
  • Jazz Pharmaceuticals presented clinical trial results at the European Society for Medical Oncology Congress.

    Some supportOct 23
  • Deutsche Bank Operational

    Jazz Pharmaceuticals engaged with a Deutsche Bank analyst to discuss its development plans.

    Some supportSep 20
  • Hoffmann-La Roche Transactional

    A drug (Zepzelca) was approved in the market alongside a Roche product (Tecentriq).

    Some supportJun 25
  • Truist Financial Mentioned together

    Truist Financial provided a buy rating and price objective for Jazz Pharmaceuticals.

    Some supportJun 21
  • Liechtenstein Shared context

    Jazz Pharmaceuticals operates within the pharmaceutical market context of Liechtenstein.

    SpeculativeJul 6
  • PharmaMar Transactional

    The relationship involved a specific, time-bound partnership where the Phase 3 clinical trial for Jazz's drug was conducted.

    Some supportJun 17
  • Buy Mentioned together

    No evidence was found linking Jazz Pharmaceuticals and Buy.

    Some supportJul 31

History

Events by the month they began
Show 2 earlier months

June 2026

31 events